Endocarditis on Hemodialysis: Link Bloodstream and Access

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Monitor cultures, clinical response, drug-related adverse effects, and access planning. Treatment success requires resolution of the infection pathway.

Access infection can reach a heart valve. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Access infection can reach a heart valve. Vascular access — Potential bloodstream entry; Bacteremia — Obtain clinically indicated cultures; Valve infection — Imaging and source evaluation; Systemic consequences — Embolic or immune injury may occur. Manage infection and source control together; a dressing problem can be a systemic infection. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

High exposure, high stakes

Repeated vascular access and bloodstream infection risk make endocarditis an important consideration in dialysis patients with persistent bacteremia or systemic illness.

Look for more than fever

Embolic signs, new cardiac findings, access abnormalities, persistent positive cultures, and unexplained deterioration can reveal a deeper infection.

Define the organism and source

Blood cultures, appropriate echocardiography, access assessment, and susceptibility testing guide diagnosis and treatment. Prior antibiotics can complicate interpretation.

Coordinate treatment

Coordinate infectious disease, nephrology, cardiology, and surgery. Choose susceptibility-directed treatment and dialysis-adjusted exposure; intermittent dialysis-day-only regimens are not established replacements for standard therapy.

Do not ignore source control

An infected catheter, persistent bacteremia, valve complications, or metastatic infection may prevent cure despite an apparently appropriate antibiotic.

Follow for relapse and harm

Monitor cultures, clinical response, drug-related adverse effects, and access planning. Treatment success requires resolution of the infection pathway.

Supporting evidence

Continue learning